Detalhe da pesquisa
1.
Protocol digest of a randomized controlled adaptive Phase II/III trial of neoadjuvant chemotherapy for Japanese patients with oesophagogastric junction adenocarcinoma: Japan Clinical Oncology Group Study JCOG2203 (NEO-JPEG).
Jpn J Clin Oncol
; 54(2): 206-211, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37952093
2.
Usefulness of an S-1 dosage formula: an exploratory analysis of randomized clinical trial (JCOG1001).
Gastric Cancer
; 25(6): 1073-1081, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767198
3.
Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis.
Invest New Drugs
; 38(2): 533-540, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31264067
4.
Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab.
BMC Cancer
; 19(1): 974, 2019 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31638948
5.
[Nivolumab Treatment for the Patients with Gastric Cancer-Present and Future].
Gan To Kagaku Ryoho
; 46(10): 1513-1523, 2019 Oct.
Artigo
em Japonês
| MEDLINE | ID: mdl-31631132
6.
Targeting AURKA in treatment of peritoneal tumor dissemination in gastrointestinal cancer.
Transl Oncol
; 16: 101307, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902741
7.
CD11b+CTLA4+ myeloid cells are a key driver of tumor evasion in colorectal cancer.
J Immunother Cancer
; 9(7)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34261702
8.
Targeting Oncoimmune Drivers of Cancer Metastasis.
Cancers (Basel)
; 13(3)2021 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33535613
9.
CD11b+DIP2A+LAG3+ cells facilitate immune dysfunction in colorectal cancer.
Am J Cancer Res
; 11(11): 5428-5439, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34873470
10.
Tumor growth rate during re-challenge chemotherapy with previously used agents as salvage treatment for metastatic colorectal cancer: A retrospective study.
PLoS One
; 16(9): e0257551, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34559818
11.
Development of chemotherapeutics for unresectable advanced esophageal cancer.
Expert Rev Anticancer Ther
; 20(12): 1083-1092, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32820965
12.
IL33 Is a Key Driver of Treatment Resistance of Cancer.
Cancer Res
; 80(10): 1981-1990, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32156776
13.
Linked color imaging improves the endoscopic visibility of gastric mucosal cancers.
Endosc Int Open
; 7(2): E164-E170, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30705948
14.
Hyperprogressive disease during nivolumab or irinotecan treatment in patients with advanced gastric cancer.
ESMO Open
; 4(3): e000488, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31231567